Skip to main content
Clinical Trials/NCT04342364
NCT04342364CompletedNot Applicable

Oocyte Survival After Vitrification With Slush Nitrogen Compared With Liquid Nitrogen

Reproductive Medicine Associates of New Jersey1 site in 1 country27 target enrollmentStarted: April 8, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
27
Locations
1
Primary Endpoint
oocyte survival rate

Study Overview

Brief Summary

The purpose of this study is to determine if the use of slush nitrogen results in higher post-thaw survival rates for oocytes compared to conventionally used liquid nitrogen.

Detailed Description

The study is a randomized, controlled trial which seeks to characterize oocyte survival rate following vitrification and subsequent warming with both slush nitrogen and liquid nitrogen. After warming, fertilization and embryology outcomes will be assessed.

Oocyte donors and a single donor sperm source will be utilized. Following enrollment, oocyte donors will undergo ovarian stimulation and oocyte retrieval. The mature (MII) oocytes obtained for each patient will then be assigned a number and randomized via block randomization to one of two treatment groups (liquid nitogen or slush nitrogen). Through block randomization, this will create a paired population of oocytes so that half of each patient's oocytes will undergo cryopreservation with liquid nitrogen and half will undergo cryopreservation with slush nitrogen. Timing of hyaluronidase stripping and vitrification will be consistent with current institutional clinical practice for oocytes.

Following cryopreservation, oocytes will be warmed and intracytoplasmic sperm injection will be performed and subsequent embryology outcomes tracked.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
Single (Outcomes Assessor)

Masking Description

embryologist assessing oocyte survival (primary outcome) is blinded

Eligibility Criteria

Ages
18 Years to 30 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Major Inclusion Criteria for oocyte donors:
  • •Age 30 years or younger who meet institutional criteria to be an oocyte donor.
  • •Patients who agree to donate oocytes for research purposes and agree to the study protocol.
  • •The subgroup of oocyte donors age 35-38 will not be part of the primary analysis, and therefore will not be required to meet the age criteria listed above. The older group of donors will be chosen as the clinical discretion of the study investigators. No specific ovarian reserve cutoffs will be required, although factors related to ovarian reserve will be taken into consideration.

Exclusion Criteria

  • •for oocyte donors:
  • •Under 18 years old
  • •All patients who do not voluntarily give their written consent for participation.
  • •Patients who do not meet standard institutional criteria for oocyte donation.
  • •A diagnosis of polycystic ovarian syndrome (PCOS).

Arms & Interventions

Slush nitrogen

Active Comparator

oocytes are randomized to undergo vitrification utilizing slush nitrogen

Intervention: Vitrification via slush nitrogen (Other)

Liquid Nitrogen

Active Comparator

oocytes are randomized to undergo vitrification utilizing liquid nitrogen which is the current standard of care

Intervention: Vitrification via liquid nitrogen (Other)

Outcomes

Primary Outcomes

oocyte survival rate

Time Frame: within 5 minutes post warming

number of viable oocytes post warming

Secondary Outcomes

  • euploid rate(1 week after trophectoderm biopsy)
  • fertilization rate(18 hours post injection)
  • blastulation rate(4-6 days after fertilization)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials